Concepedia

Antonella Napolitano

AN

25

Publications

1.4K

Citations

19

H-Index

1998

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

University of Cambridge

GlaxoSmithKline (United States)

Addenbrooke's Hospital

Research Triangle Park Foundation

Antonella Napolitano is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, obesity, and physiology.

Top concepts

Publications per year

1998–2020

25

Publications

25

Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus

Antonella Napolitano, Sam Miller, Andrew W. Nicholls et al. · PLoS ONE · 2014 · 280 citations · Full text

The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans

Boris A. Chizh, M. O'Donnell, Antonella Napolitano et al. · Pain · 2007 · 244 citations

11β-hydroxysteroid dehydrogenase 1 in adipocytes: Expression is differentiation-dependent and hormonally regulated

Antonella Napolitano, Michael W. Voice, Christopher R.W. Edwards et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1998 · 117 citations

, , +9

Neural and Behavioral Effects of a Novel Mu Opioid Receptor Antagonist in Binge-Eating Obese People

Victoria C. Cambridge, Hisham Ziauddeen, Pradeep J. Nathan et al. · Biological Psychiatry · 2012 · 92 citations · Full text

Validation of a Quantitative Magnetic Resonance Method for Measuring Human Body Composition

Antonella Napolitano, Sam R. Miller, Peter R. Murgatroyd et al. · Obesity · 2008 · 85 citations

Rows per page

1–5 of 25